Although solid tumors cells are believed to be more dependent on BCL-XL than hematologic malignancies, our results suggest that some AML cases, for example, BRCA2- or IDH2-mutated, may need this particular protein more than the other BCL2 family members for their survival. Here, BRCA2 is linked to hematologic disorder.